Growing confidence in the life sciences industry and the currency of individual experience has given patient centricity an injection of new life. It has also been essential in suppressing the coronavirus and establishing humanity’s position in the race against time
Collaborative working is a cornerstone of the government’s White Paper for the NHS, but how can pharmaceutical companies best get in on the act? Wilmington Healthcare’s Oli Hudson looks at six distinct ways in which industry can partner with NHS organisations to mutual advantage
The healthcare industry has successfully brought effective vaccines to market despite massive disruption from COVID-19. But with global supply chains still stretched, what are the priorities for supply chain players as we move towards a ‘new normal’?
In recent months an intense debate has arisen about a potential waiving of patent rights on COVID vaccines. This article looks at the background to this debate, the relevance of patent rights to the COVID vaccines and the various issues raised by the different protagonists.